5mm injection needle

Details 5mm injection needle 5mm injection needle

1997-06-05

2001-03-13

Yasko, John D. (Department: 3734)

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

C604S117000

Reexamination Certificate

active

06200296

ABSTRACT:

BACKGROUND OF THE INVENTION
1. Field of the Invention
The subject invention relates to a 0.197″ (5 mm) needle for making injections into the subcutaneous layer in the tissue “strata” of a patient and, more particularly, a 5 mm needle having a 31 gauge cannula for use on a medication delivery pen or hypodermic syringe.
2. Background Description
Medication delivery pens are hypodermic syringes used for self-injection of precisely measured doses of medication. Pens are widely used, for example, by diabetics to dispense insulin.
A typical prior art medication delivery pen includes a cartridge which contains a volume of liquid medication sufficient for several doses. The cartridge includes an elongated generally tubular glass cartridge having a pierceable rubber septum which extends across the open distal end of the cartridge and is securely held in position by a metallic sleeve that is crimped to the distal end of the cartridge. The cartridge also includes a rubber stopper in sliding fluid-tight engagement with interior walls of the cartridge.
Such a medication delivery pen also includes a unitarily molded cartridge retainer having a small diameter tubular neck dimensioned for tightly engaging the neck of the cartridge and the metallic sleeve crimped thereon so as to support and position the entire cartridge. Exterior regions at the extreme distal end of the tubular neck are formed with an array of threads for threadedly receiving the mounting cap of a needle assembly. The medication delivery pen further includes a dosing apparatus that is engaged with the proximal end of the cartridge retainer having a plunger for engaging the rubber stopper of the cartridge. The dosing apparatus includes a dose setting structure used to select the longitudinal distance through which the plunger will move, and dispensing means for driving the plunger the selected distance.
The needle assembly for the medication delivery pen includes an elongate needle cannula having opposed proximal and distal points and a lumen extending therethrough. A plastic cork is adhered to an intermediate position along the needle cannula and in turn is rigidly connected to an end wall of a cylindrical cap. The cylindrical wall of the cap surrounds the proximal point on the needle cannula and includes an array of internal threads for engaging the external threads on the neck of the cartridge retainer.
The medication delivery pen may be used by urging the cap of the needle assembly over the neck of the cartridge retainer sufficiently for the proximal point of the needle cannula to pierce the rubber septum of the cartridge. The cap is then rotated to threadedly engage the neck of the cartridge retainer. The user then manipulates the dosing apparatus to select an appropriate dose. A protective shield over the distal end of the needle cannula is then removed, and the distal point of the needle cannula is injected. The user then actuates the dispensing means of the prior art dosing apparatus to urge the stopper of the cartridge distally and to deliver medication through the lumen of the needle cannula. The needle is then withdrawn, and the needle assembly is separated from the cartridge retainer and safely discarded. The rubber septum of the cartridge reseals itself, and may be pierced again for a subsequent administration of medication. This process may be carried out repeatedly until all of the medication in the cartridge has been used.
A problem with currently available needle assemblies for use on medication delivery pens is the size of the cannula. Prior to the present invention, 27, 28, 29 and 30 gauge needle cannulas have been commonly used on medication delivery pens, with 30 gauge being the smallest diameter possible. Even though smaller gauges, i.e., 29 and 30 gauge, have helped to reduce pain to patients during injection, there is still a need to provide needle assemblies for medication delivery pens with smaller cannula diameters since small diameter needles are perceived by patients to cause less pain during the injection. However, no one skilled in the art has suggested and no one has provided patients with needle assemblies having a diameter less than 30 gauge.
Another problem with currently available needle assemblies for use on medication delivery pens or with hypodermic syringes is the need for the user or patient to “pinch up” at the injection site to ensure that the injection of the medication is into subcutaneous tissue. It has been found that injections of medication into the muscle layer can be painful. Therefore, it is desirable to have a new needle assembly for use on medication delivery pens and hypodermic syringes that eliminates the need for “pinch up” and deliver a dose of medication to a proper location in the tissue “strata”.
SUMMARY OF THE INVENTION
The present invention overcomes the 30 gauge limit that has existed for pen needle assemblies by providing a 31 gauge needle assembly for use on medication delivery pens. The 31 gauge needle provides a patient with a needle assembly having a smaller cannula size without loss in performance or structural integrity. The 31 gauge needle assembly mounts on a needle mounting tip of a cartridge retainer assembly on a medication delivery pen and is used like prior art needle assemblies to pierce a patient's arm during an injection process.
However, since the 31 gauge needle cannula is smaller than prior art needle cannulas the penetration force is decreased which reduces the pain caused during an injection procedure. In addition, the smaller cannula size will be seen by the patient prior to the injection so that perceived pain or anticipated pain is also reduced. The reduction in actual and perceived/anticipated pain provided by using the 31 gauge needle on the medication delivery pen is a major benefit to patients that need numerous injections each day, i.e., diabetics requiring insulin injections.
Another aspect of the present invention is providing a needle having a minimal usable length that can deliver a dose of medication to a proper location in the tissue “strata” or subcontinuous layer. The present invention provides a needle with a usable length of 5 mm for making such an injection and medication delivery, wherein the need for the user or patient to “pinch-up” the skin layer during the injection is eliminated.
These and other aspects, features and advantages of the present invention will become apparent from the following detailed description taken in conjunction with the accompanying drawings.


REFERENCES:
patent: 4313439 (1982-02-01), Babb et al.
patent: 4552561 (1985-11-01), Eckenhoff et al.
patent: 4692142 (1987-09-01), Dignam et al.
patent: 4894054 (1990-01-01), Miskinyar
patent: 4917670 (1990-04-01), Hurley et al.
patent: 4944677 (1990-07-01), Alexandre
patent: 4969884 (1990-11-01), Yum
patent: 4973318 (1990-11-01), Holm et al.
patent: 5015235 (1991-05-01), Crossman
patent: 5151093 (1992-09-01), Theeuwes et al.
patent: 5279586 (1994-01-01), Balkwill
patent: 5295976 (1994-03-01), Harris
patent: 5374256 (1994-12-01), Kriesel
patent: 5462535 (1995-10-01), Bonnichsen et al.
patent: 5540357 (1996-07-01), Kurjan et al.
patent: 5599323 (1997-02-01), Bonnichsen et al.
patent: 5709668 (1998-01-01), Wacks
patent: 5951530 (1999-09-01), Steengaard et al.
patent: 5984906 (1999-11-01), Bonnichsen et al.
patent: 279583 B1 (1993-10-01), None
patent: 0702970 A2 (1996-03-01), None
patent: 3-275214 (1991-12-01), None
patent: 4-502877 (1992-05-01), None
patent: 6-86745 (1994-12-01), None
patent: WO 90/07348 (1990-07-01), None
patent: 92/17131 (1992-10-01), None
patent: 93/00948 (1993-01-01), None
patent: WO 93/07922 (1993-04-01), None
patent: 93/07877 (1993-04-01), None
patent: WO 95/12425 (1995-05-01), None
“Announcing The New Micro-Fine IV Pen Needle”, pp. BD 386-BD 389, published Jul. 1, 1991.
Australian Standard 2145-1985, “Hypodermic Equipment-Hypodermic Needle Tubing”, published by The Standards Association of Australia, Jul. 12, 1985, pp. 24-37.
NovoFine 30G 8mm, “NovoFine reduces pain and the risk of intramuscular injections”, pp. 18.1-18.4,

Affiliated with

Also associated with

Rating

5mm injection needle does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5mm injection needle, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5mm injection needle will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2438939